Comparison

CDK7-IN-14 European Partner

Item no. TMO-T63108-5mg
Manufacturer TargetMol
CASRN 2765676-49-9
Amount 5 mg
Category
Type Inhibitors
Specific against other
Smiles CP(C)(=O)c1c(ccc2c(c[nH]c12)-c1nc(N[C@H]2CCC[C@H](N)C2)ncc1C(F)(F)F)C#N
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Short Description
CDK7-IN-14 is a pyrimidine-derived compound that is a potent inhibitor of CDK7. CDK7-IN-14 has the potential to be investigated in a variety of cancers, particularly those with transcriptional dysregulation, for more information please refer to patent CN114249712A, compound 3.
Shipping
cool pack
Storage
-20°
Molecular Weight
476, 444

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close